These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

732 related items for PubMed ID: 28376031

  • 1. The Immune Response to Epstein Barr Virus and Implications for Posttransplant Lymphoproliferative Disorder.
    Martinez OM, Krams SM.
    Transplantation; 2017 Sep; 101(9):2009-2016. PubMed ID: 28376031
    [Abstract] [Full Text] [Related]

  • 2. Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56dimNKG2A+KIR- NK Cells and Contributes to Suboptimal Control of EBV in Immunosuppressed Children With Post-transplant Lymphoproliferative Disorder.
    Lam JKP, Azzi T, Hui KF, Wong AMG, McHugh D, Caduff N, Chan KH, Münz C, Chiang AKS.
    Front Immunol; 2020 Sep; 11():1231. PubMed ID: 32625211
    [Abstract] [Full Text] [Related]

  • 3. The Changing Epidemiology of Posttransplant Lymphoproliferative Disorder in Adult Solid Organ Transplant Recipients Over 30 Years: A Single-center Experience.
    Peters AC, Akinwumi MS, Cervera C, Mabilangan C, Ghosh S, Lai R, Iafolla M, Doucette K, Preiksaitis JK.
    Transplantation; 2018 Sep; 102(9):1553-1562. PubMed ID: 29485513
    [Abstract] [Full Text] [Related]

  • 4. EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder.
    Hart M, Thakral B, Yohe S, Balfour HH, Singh C, Spears M, McKenna RW.
    Am J Surg Pathol; 2014 Nov; 38(11):1522-9. PubMed ID: 25007145
    [Abstract] [Full Text] [Related]

  • 5. Epstein-Barr virus-positive mucocutaneous ulcer arising in a post-hematopoietic cell transplant patient followed by polymorphic posttransplant lymphoproliferative disorder and cytomegalovirus colitis.
    Satou A, Kohno A, Fukuyama R, Elsayed AA, Nakamura S.
    Hum Pathol; 2017 Jan; 59():147-151. PubMed ID: 27569297
    [Abstract] [Full Text] [Related]

  • 6. Epstein-Barr virus, rapamycin, and host immune responses.
    Krams SM, Martinez OM.
    Curr Opin Organ Transplant; 2008 Dec; 13(6):563-8. PubMed ID: 19060543
    [Abstract] [Full Text] [Related]

  • 7. Genomic variations in EBNA3C of EBV associate with posttransplant lymphoproliferative disorder.
    Maloney EM, Busque VA, Hui ST, Toh J, Fernandez-Vina M, Krams SM, Esquivel CO, Martinez OM.
    JCI Insight; 2020 Mar 26; 5(6):. PubMed ID: 32213705
    [Abstract] [Full Text] [Related]

  • 8. Epstein-Barr virus: evasive maneuvers in the development of PTLD.
    Snow AL, Martinez OM.
    Am J Transplant; 2007 Feb 26; 7(2):271-7. PubMed ID: 17229074
    [Abstract] [Full Text] [Related]

  • 9. Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients.
    San-Juan R, Comoli P, Caillard S, Moulin B, Hirsch HH, Meylan P, ESCMID Study Group of Infection in Compromised Hosts.
    Clin Microbiol Infect; 2014 Sep 26; 20 Suppl 7():109-18. PubMed ID: 24475976
    [Abstract] [Full Text] [Related]

  • 10. The Epstein-Barr virus and post-transplant lymphoproliferative disease: interplay of immunosuppression, EBV, and the immune system in disease pathogenesis.
    Tanner JE, Alfieri C.
    Transpl Infect Dis; 2001 Jun 26; 3(2):60-9. PubMed ID: 11395971
    [Abstract] [Full Text] [Related]

  • 11. Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases.
    Nash RA, Dansey R, Storek J, Georges GE, Bowen JD, Holmberg LA, Kraft GH, Mayes MD, McDonagh KT, Chen CS, Dipersio J, Lemaistre CF, Pavletic S, Sullivan KM, Sunderhaus J, Furst DE, McSweeney PA.
    Biol Blood Marrow Transplant; 2003 Sep 26; 9(9):583-91. PubMed ID: 14506660
    [Abstract] [Full Text] [Related]

  • 12. Surveillance of Epstein-Barr virus infection as a risk factor for post-transplant lymphoproliferative disorder in pediatric renal transplant recipients.
    Köpf S, Tönshoff B.
    Pediatr Nephrol; 2004 Apr 26; 19(4):365-8. PubMed ID: 14963763
    [Abstract] [Full Text] [Related]

  • 13. Primary Cutaneous Polymorphic EBV-Associated Posttransplant Lymphoproliferative Disorder After a Renal Transplant and Review of the Literature.
    Ferguson NN, Thomas CP, Hohl RJ, Syrbu SI, Stone MS, Wanat KA.
    Am J Dermatopathol; 2015 Oct 26; 37(10):790-4. PubMed ID: 25747810
    [Abstract] [Full Text] [Related]

  • 14. Identifying predictive factors for posttransplant lymphoproliferative disease in pediatric solid organ transplant recipients with Epstein-Barr virus viremia.
    Weintraub L, Weiner C, Miloh T, Tomaino J, Joashi U, Benchimol C, Strauchen J, Roth M, Wistinghausen B.
    J Pediatr Hematol Oncol; 2014 Nov 26; 36(8):e481-6. PubMed ID: 24878618
    [Abstract] [Full Text] [Related]

  • 15. A low incidence of posttransplant lymphoproliferative disorder in 109 lung transplant recipients.
    Levine SM, Angel L, Anzueto A, Susanto I, Peters JI, Sako EY, Bryan CL.
    Chest; 1999 Nov 26; 116(5):1273-7. PubMed ID: 10559086
    [Abstract] [Full Text] [Related]

  • 16. Quantitative analysis of EBV-specific CD4/CD8 T cell numbers, absolute CD4/CD8 T cell numbers and EBV load in solid organ transplant recipients with PLTD.
    Sebelin-Wulf K, Nguyen TD, Oertel S, Papp-Vary M, Trappe RU, Schulzki A, Pezzutto A, Riess H, Subklewe M.
    Transpl Immunol; 2007 Apr 26; 17(3):203-10. PubMed ID: 17331848
    [Abstract] [Full Text] [Related]

  • 17. Primary Epstein-Barr virus infection, seroconversion, and post-transplant lymphoproliferative disorder in seronegative renal allograft recipients: a prospective cohort study.
    Hosseini-Moghaddam SM, Alhomayeed B, Soliman N, Weir MA, House AA.
    Transpl Infect Dis; 2016 Jun 26; 18(3):423-30. PubMed ID: 27016725
    [Abstract] [Full Text] [Related]

  • 18. Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease.
    Smets F, Latinne D, Bazin H, Reding R, Otte JB, Buts JP, Sokal EM.
    Transplantation; 2002 May 27; 73(10):1603-10. PubMed ID: 12042647
    [Abstract] [Full Text] [Related]

  • 19. Epstein-Barr virus-related disorders in children undergoing renal transplantation with tacrolimus-based immunosuppression.
    Ellis D, Jaffe R, Green M, Janosky JJ, Lombardozzi-Lane S, Shapiro R, Scantlebury V, Vivas C, Jordan ML.
    Transplantation; 1999 Oct 15; 68(7):997-1003. PubMed ID: 10532541
    [Abstract] [Full Text] [Related]

  • 20. Strategies to prevent EBV reactivation and posttransplant lymphoproliferative disorders (PTLD) after allogeneic stem cell transplantation in high-risk patients.
    Reddy N, Rezvani K, Barrett AJ, Savani BN.
    Biol Blood Marrow Transplant; 2011 May 15; 17(5):591-7. PubMed ID: 20732435
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.